Handbook of Cell and Gene Therapy: From Proof-of-Concept through Manufacturing to Commercialization

Author:   Hazel Aranha (GAEA Resources, Inc., USA) ,  Humberto Vega-Mercado
Publisher:   Taylor & Francis Ltd
ISBN:  

9781032257976


Pages:   350
Publication Date:   17 March 2023
Format:   Hardback
Availability:   In Print   Availability explained
This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us.

Our Price $273.00 Quantity:  
Add to Cart

Share |

Handbook of Cell and Gene Therapy: From Proof-of-Concept through Manufacturing to Commercialization


Add your own review!

Overview

Full Product Details

Author:   Hazel Aranha (GAEA Resources, Inc., USA) ,  Humberto Vega-Mercado
Publisher:   Taylor & Francis Ltd
Imprint:   CRC Press
Weight:   1.400kg
ISBN:  

9781032257976


ISBN 10:   1032257970
Pages:   350
Publication Date:   17 March 2023
Audience:   College/higher education ,  Professional and scholarly ,  Tertiary & Higher Education ,  Professional & Vocational
Format:   Hardback
Publisher's Status:   Active
Availability:   In Print   Availability explained
This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us.

Table of Contents

History of Gene Therapy Products; Overview of technologies applied to gene therapy products; History of Cell Therapy Products; Overview of technologies applied to cell therapy products – what it entails; Gene Therapy Manufacturing- an Overview on Viral Vectors and Plasmid Manufacturing, Does it suffice; Basic considerations – Manufacturing Processes: - Cell therapy products; Analytical Methods; Facility and equipment considerations; Control of adventitious agent contamination during manufacture of cell and gene therapy products; Quality Considerations from Clinical to Commercial Manufacturing; Regulatory Compliance and Approval; CMC Submissions; Validation, Verification and Qualification Considerations; Clinical development of cell and gene therapies –from first-in-human to postmarketing studies; Risk-based approach in the development of cell and gene therapy products; Current global regulatory landscape; Comparison of EU and US Regulatory Requirements; Regulatory Landscape for Gene and Cell Therapies; Canada; China; Regulation of cell product and gene therapy; South Asia Countries; Japan; Regulatory Pathway for Cell, Tissue and Gene Therapy Products in Singapore; Regulatory Pathway for Cell and Gene Therapy Products in Malaysia; The Regulation of Cell and Gene Therapy Products in Australia and New Zealand; Pricing and market access: the market access hurdle; Training Approaches to Build Cell and Gene Therapy Workforce Capacity; Lessons Learned – Successes and Pitfalls; Pitfall Avoidance through Cross-Functional Development Approach

Reviews

Just spreading the exciting news: Humberto Vega, one of the pharmaceutical industry's icon's in the cell and gene therapy space, recently released a book that describes a soup-to-nuts approach to commercialization of cell and gene therapies. It is rare to find any publications in this area that are this comprehensive and cover activities spanning from the early development phase all the way to commercialization. The book is written for a diverse audience that ranges from researchers, scientists and management to academic and research institutions--basically anyone involved in the support of the core technologies and supportive practices in this space. It is widely available for purchase on Amazon, Barnes and Noble, Routledge and many other sources. Congratulations to Humberto Vega and HAZEL ARANHA! - Brian Kirk The cell and gene therapies industry is growing rapidly. The ""Handbook of Cell and Gene Therapy"" is fresh off the presses and contains the latest details on the development, production, and delivery of life-saving cell and gene therapy materials. Co-editor Hazel Aranha, PhD, knows her stuff! Because I edit scientific bioprocessing papers from researchers and commercial production people, I need to stay on top of my knowledge base. This handbook will help me significantly. I am happy to own the book -- as of March 26, 2023 -- and have already started reading it. - Marcie Brown


Just spreading the exciting news: Humberto Vega, one of the pharmaceutical industry's icon's in the cell and gene therapy space, recently released a book that describes a soup-to-nuts approach to commercialization of cell and gene therapies. It is rare to find any publications in this area that are this comprehensive and cover activities spanning from the early development phase all the way to commercialization. The book is written for a diverse audience that ranges from researchers, scientists and management to academic and research institutions--basically anyone involved in the support of the core technologies and supportive practices in this space. It is widely available for purchase on Amazon, Barnes and Noble, Routledge and many other sources. Congratulations to Humberto Vega and HAZEL ARANHA! - Brian Kirk The cell and gene therapies industry is growing rapidly. The Handbook of Cell and Gene Therapy is fresh off the presses and contains the latest details on the development, production, and delivery of life-saving cell and gene therapy materials. Co-editor Hazel Aranha, PhD, knows her stuff! Because I edit scientific bioprocessing papers from researchers and commercial production people, I need to stay on top of my knowledge base. This handbook will help me significantly. I am happy to own the book -- as of March 26, 2023 -- and have already started reading it. - Marcie Brown


Author Information

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions
Latest Reading Guide

MRG2025CC

 

Shopping Cart
Your cart is empty
Shopping cart
Mailing List